Singapore, April 29 -- ekincare, India's leading artificial intelligence (AI)-powered integrated digital health gateway, has announced the raising of a strategic, undisclosed investment led by global healthcare leader MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA) through MSD IDEA Studio Asia Pacific, an initiative by the MSD Global Health Innovation Fund (MGHIF).

The round also saw participation from ekincare's existing investor, HealthQuad, a venture capital fund focused on healthcare innovation. This investment round will empower ekincare to advance its mission of revolutionizsng corporate primary and preventive healthcare through AI-driven, personalised Outpatient Department (OPD) solutions.

With this investment, ekincare a...